Introduction to the 2024 Consensus Guidelines for the Management of Neutropenic Fever in Patients with Cancer: Principles & Practice of Neutropenic Fever.

Saved in:
Bibliographic Details
Title: Introduction to the 2024 Consensus Guidelines for the Management of Neutropenic Fever in Patients with Cancer: Principles & Practice of Neutropenic Fever.
Authors: Thursky KA; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Department of Infectious Diseases, University of Melbourne, Melbourne, Victoria, Australia.; National Centre for Antimicrobial Stewardship, Department of Infectious Diseases, University of Melbourne, Melbourne, Victoria, Australia.; Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Singh N; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Slavin MA; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Victorian Infectious Diseases Service, The Peter Doherty Institute for Immunity and Infection, Royal Melbourne Hospital, Melbourne, Victoria, Australia., Weinkove R; Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand.; Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.; Wellington Blood & Cancer Centre, Wellington Regional Hospital, Wellington, New Zealand., Haeusler GM; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Department of Infectious Diseases, Royal Children's Hospital, Melbourne, Victoria, Australia.; Murdoch Children's Research Institute, Melbourne, Victoria, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.; The Paediatric Integrated Cancer Service, Victoria State Government, Melbourne, Victoria, Australia., Hickman J; Patient Experience and Wellbeing, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Jessop S; Michael Rice Department of Haematology and Oncology, Women's and Children's Hospital, Adelaide, South Australia, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, New South Wales, Australia., Lambros B; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia., Routledge D; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Sasadeusz J; Department of Infectious Diseases, University of Melbourne, Melbourne, Victoria, Australia.; Victorian Infectious Diseases Service, The Peter Doherty Institute for Immunity and Infection, Royal Melbourne Hospital, Melbourne, Victoria, Australia., Roberts JA; University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Herston Infectious Diseases Institute (HeIDI), Metro North Health, Brisbane, Queensland, Australia.; Department of Pharmacy, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; UR UM 103, University of Montpellier, Division of Anesthesia Critical Care and Emergency and Pain Medicine, Nimes University Hospital, Nimes, France., Mileshkin LR; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Conyers R; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.; Cancer Therapies Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.; Children's Cancer Centre, The Royal Children's Hospital, Melbourne, Victoria, Australia., Douglas AP; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Department of Infectious Diseases and Immunology, Austin Health, Melbourne, Victoria, Australia.
Corporate Authors: Australasian Neutropenic Fever Guidelines Steering Committee
Source: Internal medicine journal [Intern Med J] 2025 Dec; Vol. 55 Suppl 7, pp. 9-19.
Publication Type: Journal Article; Review
Journal Info: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 101092952 Publication Model: Print Cited Medium: Internet ISSN: 1445-5994 (Electronic) Linking ISSN: 14440903 NLM ISO Abbreviation: Intern Med J Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1445-5994
DOI:10.1111/imj.70237